OWCP: Very interesting

New Post Public Reply Private Reply Replies (1) Message Board
joey68
OWCP: Very interesting news..

http://www.investopedia.com/news/teva-market-...rael-teva/

Why is this interesting?

Not to long ago, TEVA tried to buy OWCP's patents. It is clear TEVA is the real deal.

It is possible, now that TEVA is growing rapidly, that they will offer an even better buyout price to OWCP in the future.

Not investment advice

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Svitzer Group Announces Major Shareholder Notification

Updated Category News Views 258

Major Shareholder Notification from Morgan Stanley In accordance with the Danish Capital Markets Act, Svitzer Group A/S, recognized by CVR-no. 44 79 14 47, shares an important notification regarding its major shareholder. Morgan Stanley recently disclosed that as of a specified date, it directly or indirectly holds 1,642,654 shares in Svitzer Group. This corresponds to...

Continue Reading
Petco Health and Wellness Faces Legal Action: Key Investor Insights

Updated Category News Views 93

Understanding Petco Health and Wellness Legal Challenges Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) has recently encountered significant legal challenges that may impact its investors. As a notable player in the pet health and wellness sector, Petco is dedicated to improving the lives of pets and their owners. However, the company is currently under scrutiny...

Continue Reading
Survey Shows Users Favor Unrestricted AI Interaction

Updated Category News Views 116

Survey Reveals User Preferences for AI Interaction A recent survey conducted by Muah AI has shed light on user preferences, revealing a strong inclination towards uncensored large language models (LLMs). More than 85% of the 25,000 active respondents expressed a desire for less restrictive communication tools. This finding indicates a growing demand for more open and...

Continue Reading
Dyne Therapeutics Set to Shine at Upcoming Research Conference

Updated Category News Views 224

Dyne Therapeutics Announces Presentations at Major Conference Dyne Therapeutics, Inc (NASDAQ: DYN), primarily known for its dedication to advancing therapeutics for neuromuscular diseases, is gearing up to showcase its innovative research at the upcoming MDA Clinical & Scientific Conference. This event is scheduled to take place from March 16-19, 2025, and will feature a...

Continue Reading
Uniting Forces Against Illegal Trade for National Prosperity

Updated Category News Views 147

Strengthening the Fight Against Illegal Trade Public and private sector security experts have gathered to address the escalating threat of illegal trade and its impact on American society. Over 75 leaders recently met at the USA-IT 2025 National Summit to call on Congress for new policies aimed at dismantling the $2.2 trillion underground economy, which encompasses...

Continue Reading